Did you know you can now get UNLIMITED CE Hours for only $74.95?
Click Here to learn more.

CEU Course Description

This short CEU course focuses on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system.  Both the adverse and the potential therapeutic effects of the cannabinoid system are discussed.

Article Author: Ken Mackie, M.D., et al.
Exam writer:  Patricia Hocking-Walker, M.S. (Psychology)

CEU Course Objectives

1.  Explain the relationship between anandamide / CB1 receptor signaling and anxiety and fear.

2.  Investigate the factors that can affect the association between adolescent cannabis use and increased risk for psychosis.

3.  Identify the “stress-responsive” endocannabinoid.

4.  Describe the cannabinoid that is effective at controlling specific cardinal symptoms of multiple sclerosis.

ACE credit is not offered for this course. A list of courses offering ACE credit can be found here.

CAADE Approval

This course does not have CAADE approval for CEUs.

Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.

*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at support@quantumunitsed.com.

Added On: 04/16/2017